Connect with us at BIO International Convention Digital Event 2021!
Updates for A166 (HER2 ADC) will be presented at 2022 ASCO Annual Meeting
Clinical updates will be presented at 2022 ASCO for the Phase 1 dose-expansion study of A166 in HER2+ metastatic breast cancer.
May 29, 2022
KLUS Pharma is Attending 40th Annual J.P. Morgan Health Care Conference
KLUS Pharma will attend the 40th Annual J.P. Morgan Health Care Conference to be held virtually from January 10-13, 2022
January 1, 2022
Kelun-Biotech and Ellipses Pharma Announce a Licensing Agreement for A400
Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. and UK company Ellipses Pharma Ltd. Announce a Licensing Agreement for Innovative Small Molecule Cancer Therapeutics
March 26, 2021